Contrast Enhanced Digital Mammography (CEDM) Market (Application: Screening and Diagnostics; Technique: Temporal Subtraction and Dual Energy CEDM; and End User: Hospitals, Diagnostic Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2030

Description

AI-powered Image Processing Forms Gold Standard for Breast Cancer Diagnosis

The contrast enhanced digital mammography (CEDM) market is witnessing change with the introduction of software in mammography equipment. Advancements in mammography software are anticipated to create incremental opportunities for healthcare companies. Mammography software is boosting clinical confidence and bolstering the efficiency of mammography systems. Companies in the contrast enhanced digital mammography (CEDM) market are increasing R&D to development equipment that automatically detect breast density with the help of AI-powered image processing and computer-aided detection.

Companies in the contrast enhanced digital mammography (CEDM) market are taking keen interest in applications that offer shorter time for diagnosis. Specificity and sensitivity are setting benchmark for gold standard diagnosis for breast cancer. Since examinations are being performed in a matter of few minutes, growing awareness about breast cancer has encouraged women to undergo screening for early diagnosis of the condition. Hence, companies in the market for contrast enhanced digital mammography (CEDM) are advancing to make improvements in image acquisition processes in order to virtually prevent the issue of artifacts caused due to patient motion.

Cost and Time Efficiency of Mammography-guided Biopsy Techniques Gain Increased Popularity

Interventional and biopsy procedures play a crucial role in the diagnosis of breast cancer. Hence, companies are increasing efforts in mammography-guided biopsy techniques. For instance, in November 2019, the U.S. provider of diagnostic imaging agents, GE Healthcare, announced the launch of first-of-its-kind contrast-enhanced mammography solution Serena Bright™ for biopsy. 

Mammography-guided biopsy techniques are pervasively replacing conventional mammography and ultrasound in the contrast enhanced digital mammography (CEDM) market. Since breast MR is more time consuming, costly, and uncomfortable for patients, contrast-enhanced mammography solutions are gaining popularity in the market for contrast enhanced digital mammography.

Get a glimpse of the in-depth analysis through our Report Brochure

Contrast-enhanced mammography solutions are anticipated to become mainstream in the market for contrast enhanced digital mammography to diagnose lesions. This is justified since in 2018, diagnostics held a leading share of the contrast enhanced digital mammography (CEDM) market. Mammography-guided biopsy techniques are being highly publicized for their cost and time efficiency. Such novel techniques are anticipated to improve patient experience and outcomes. Thus, the mammography-guided biopsy technique is a potential alternative solution to traditional MR-guided breast biopsy.

Breast CT versus Digital Mammography: Which is better?

Innovations in breast imaging are emerging in the market for contrast enhanced digital mammography (CEDM) for diagnostic evaluation of symptomatic cancer patients. On the other hand, contrast-enhanced mammography solutions are creating a significant impact on breast imaging capabilities. This is evident since the contrast enhanced digital mammography (CEDM) market is anticipated to grow at a striking CAGR of 11.4% during the forecast period. However, healthcare companies in the market landscape are facing tough competition due to the advancement in technology used in dedicated cone beam breast computed tomography (CBBCT).

CBBCT is found to eliminate painful compression and manipulation of the breast. This phenomena is common in digital mammography. Hence, companies in the contrast enhanced digital mammography (CEDM) market are focusing on technical improvements in mammography equipment. They are harnessing the advantages of AI to improve the image acquisition process. Market players are increasing are experimenting with advanced reconstruction algorithms in order to enhance micro-calcifications.

Combining Dual-energy CEDM with MuCLS Results in Better Image Quality

Early breast cancer detection is one of the key drivers for the contrast enhanced digital mammography (CEDM) market. Thus, companies are increasing their efficacy in dual-energy CEDM, owing to its advantages in contrast-to-noise ratio (CNR) and spatial resolution as compared to traditional CEDM approaches. Dual energy-based two-material decomposition approach is being highly publicized in the market for contrast enhanced digital mammography (CEDM). As such, dual energy CEDM technique segment is expected to lead the contrast enhanced digital mammography (CEDM) market and is estimated for aggressive growth during the forecast period.

Healthcare providers are adopting dual energy-based two-material decomposition method for iodine image calculation for better quantification of iodine contrast agent. In order to contribute toward better image quality, companies in the market for contrast enhanced digital mammography (CEDM) are increasing awareness about the combination of Munich Compact Light Source (MuCLS) with dual energy CEDM. Thus, novel combination is clinically outperforming techniques of traditional CEDM approaches, thus creating a scope for increased revenue opportunities for healthcare companies.

Analysts’ Viewpoint

The contrast enhanced digital mammography (CEDM) market is anticipated to grow exponentially and reach a value of US$ 627.5 Mn by the end of 2027. Companies in the market are increasing efforts to innovate in HD contrast enhanced spectral mammography tools to detect malignant lesions that are otherwise uncertain to detect in conventional mammography or ultrasound.

AI is emerging as a key tool for improving the image acquisition process. However, low sensitivity in mammography acts as a challenge for healthcare companies. Hence, companies are increasing R&D to enhance image quality with deep learning and advanced reconstruction algorithms. Companies should make investments to expand in Asia Pacific, since the region is projected for exponential growth during the forecast period.

Contrast Enhanced Digital Mammography (CEDM) Market: Overview

This report analyzes the current scenario and future prospects of the global contrast enhanced digital mammography (CEDM) market. Rise in prevalence of breast cancer across the globe and implementation of breast cancer screening programs have fueled the demand for contrast enhanced digital mammography (CEDM). Moreover, increase in government initiatives to spread awareness is projected to drive the global contrast enhanced digital mammography (CEDM) market during the forecast period.

The report provides an elaborate executive summary, including a snapshot of various segments of the contrast enhanced digital mammography (CEDM) market. It also provides elaborate information and data analysis of the global contrast enhanced digital mammography (CEDM) market with regards to segments based on technology, application, end user, and region.

The overview section of the report provides a detailed qualitative analysis of drivers and restraints, and opportunities that impact the global contrast enhanced digital mammography (CEDM) market

Additionally, the report includes company profiles which provide information about their business, product portfolios, and competitive landscape in the contrast enhanced digital mammography (CEDM) market

The report on the global contrast enhanced digital mammography (CEDM) market offers attractiveness analysis of the regions and segments

The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global contrast enhanced digital mammography (CEDM) market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global contrast enhanced digital mammography (CEDM) market. 

Contrast Enhanced Digital Mammography (CEDM) Market: Key Segments

In terms of technology, the global contrast enhanced digital mammography (CEDM) market has been classified into temporal subtraction and dual energy CEDM. The temporal subtraction segment held major share of the global contrast enhanced digital mammography (CEDM) market in 2018 and the trend is anticipated to continue during the forecast period.

Based on application, the global contrast enhanced digital mammography (CEDM) market has been bifurcated into screening and diagnostic

In terms of end user, the global contrast enhanced digital mammography (CEDM) market has been divided into hospitals, diagnostics centers, specialty clinics, and others

The market value and forecast for each of these segments have been provided from 2017 to 2027. The CAGRs of respective segments have also been provided from 2019 to 2027, considering 2018 as the base year. 

Contrast Enhanced Digital Mammography (CEDM) Market: Regional Outlook

In terms of region, the global contrast enhanced digital mammography (CEDM) market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.

The contrast enhanced digital mammography (CEDM) market report provides value and forecast for each region and country/sub-region from 2017 to 2027. The compound annual growth rates (CAGR) for each of these regions and countries have also been provided for the forecast period from 2019 to 2027. The contrast enhanced digital mammography (CEDM) market study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

Key players in the global contrast enhanced digital mammography (CEDM) market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies

Major companies profiled in the global contrast enhanced digital mammography (CEDM) market report are

  • Hologic, Inc.
  • Planmed Oy
  • General Electric Company
  • Siemens Healthineers
  • Allengers 

Questions Answered in Contrast Enhanced Digital Mammography (CEDM) Market Report

  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the global contrast enhanced digital mammography (CEDM) market during the forecast period?
  • Which segment is likely to lead the contrast enhanced digital mammography (CEDM) market in terms of revenue from 2019 to 2027?
  • How mergers & acquisitions among players are widening the scope for contrast enhanced digital mammography (CEDM) market?
  • What is the market position of different companies operating in the global contrast enhanced digital mammography (CEDM) market?

Contrast Enhanced Digital Mammography (CEDM) Market - Segmentation

Application

  • Screening
  • Diagnostics

Technique

  • Temporal Subtraction
  • Dual Energy CEDM

End User

  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Contrast Enhanced Digital Mammography Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Contrast Enhanced Digital Mammography Market Analysis and Forecast, 2017–2027

5. Market Outlook

    5.1. Disease Epidemiology 

    5.2. Regulatory Scenario, by Region/globally 

    5.3. Technological Advancements

    5.4. CEDM Image Acquisition Protocol

    5.5. Screening Mammography Recommendations 

    5.6. Potential Clinical Application of CEDM

    5.7. Economic Considerations for Contrast-Enhanced Mammography Implementation 

6. Global Contrast Enhanced Digital Mammography Market Value (US$ Mn) Forecast, by Technique 

    6.1. Introduction 

    6.2. Global Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        6.2.1. Temporal Subtraction

        6.2.2. Dual Energy CEDM

    6.3. Global Contrast Enhanced Digital Mammography Market Attractiveness, by Technique

7. Global Contrast Enhanced Digital Mammography Market Value (US$ Mn) Forecast, by Application

    7.1. Introduction 

    7.2. Global Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        7.2.1. Screening

        7.2.2. Diagnostics

    7.3. Global Contrast Enhanced Digital Mammography Market Attractiveness, by Application

8. Global Contrast Enhanced Digital Mammography Market Value (US$ Mn) Forecast, by End-user

    8.1. Introduction 

    8.2. Global Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        8.2.1. Hospitals

        8.2.2. Diagnostic Centers

        8.2.3. Specialty Clinics

        8.2.4. Others 

    8.3. Global Contrast Enhanced Digital Mammography Market Attractiveness, by End-user

9. Global Contrast Enhanced Digital Mammography Market Value (US$ Mn) Forecast, by Region

    9.1. Introduction 

    9.2. Contrast Enhanced Digital Mammography Market Value Forecast, by Region, 2017–2027

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Contrast Enhanced Digital Mammography Market Attractiveness, by Region

10. North America Contrast Enhanced Digital Mammography Market Analysis and Forecast 

    10.1. Introduction

    10.2. North America Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        10.2.1. Temporal Subtraction

        10.2.2. Dual Energy CEDM

    10.3. North America Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        10.3.1. Screening

        10.3.2. Diagnostics

    10.4. North America Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Diagnostic Centers

        10.4.3. Specialty Clinics

        10.4.4. Others 

    10.5. North America Contrast Enhanced Digital Mammography Market Value Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Contrast Enhanced Digital Mammography Market Attractiveness Analysis

        10.6.1. By Technique

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Contrast Enhanced Digital Mammography Market Analysis and Forecast 

    11.1. Introduction

    11.2. Europe Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        11.2.1. Temporal Subtraction

        11.2.2. Dual Energy CEDM

    11.3. Europe Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        11.3.1. Screening

        11.3.2. Diagnostics

    11.4. Europe Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Diagnostic Centers

        11.4.3. Specialty Clinics

        11.4.4. Others 

    11.5. Europe Contrast Enhanced Digital Mammography Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy 

        11.5.6. Rest of Europe

    11.6. Europe Contrast Enhanced Digital Mammography Market Attractiveness Analysis

        11.6.1. By Technique

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Contrast Enhanced Digital Mammography Market Analysis and Forecast 

    12.1. Introduction

    12.2. Asia Pacific Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        12.2.1. Temporal Subtraction

        12.2.2. Dual Energy CEDM

    12.3. Asia Pacific Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        12.3.1. Screening 

        12.3.2. Diagnostics

    12.4. Asia Pacific Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Diagnostic Centers

        12.4.3. Specialty Clinics

        12.4.4. Others 

    12.5. Asia Pacific Contrast Enhanced Digital Mammography Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Contrast Enhanced Digital Mammography Market Attractiveness Analysis

        12.6.1. By Technique

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Contrast Enhanced Digital Mammography Market Analysis and Forecast 

    13.1. Introduction

    13.2. Latin America Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        13.2.1. Temporal Subtraction

        13.2.2. Dual Energy CEDM

    13.3. Latin America Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        13.3.1. Screening 

        13.3.2. Diagnostics

    13.4. Latin America Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Diagnostic Centers

        13.4.3. Specialty Clinics

        13.4.4. Others 

    13.5. Latin America Contrast Enhanced Digital Mammography Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Contrast Enhanced Digital Mammography Market Attractiveness Analysis

        13.6.1. By Technique 

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Contrast Enhanced Digital Mammography Market Analysis and Forecast 

    14.1. Introduction

    14.2. Middle East & Africa Contrast Enhanced Digital Mammography Market Value Forecast, by Technique, 2017–2027

        14.2.1. Temporal Subtraction

        14.2.2. Dual Energy CEDM

    14.3. Middle East & Africa Contrast Enhanced Digital Mammography Market Value Forecast, by Application, 2017–2027

        14.3.1. Screening

        14.3.2. Diagnostics

    14.4. Middle East & Africa Contrast Enhanced Digital Mammography Market Value Forecast, by End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Diagnostic Centers

        14.4.3. Specialty Clinics

        14.4.4. Others 

    14.5. Middle East & Africa Contrast Enhanced Digital Mammography Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Contrast Enhanced Digital Mammography Market Attractiveness Analysis

        14.6.1. By Technique

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Global Contrast Enhanced Digital Mammography Market Share Analysis, by Company, 2018

    15.2.  Company Profiles

        15.2.1. GE Healthcare

            15.2.1.1. Company Description

            15.2.1.2. Business Overview

            15.2.1.3. Financial Overview

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. Siemens Healthineers (Siemens AG)

            15.2.2.1. Company Description

            15.2.2.2. Business Overview

            15.2.2.3. Financial Overview

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. Allengers Medical Systems Limited

            15.2.3.1. Company Description

            15.2.3.2. Business Overview

            15.2.3.3. Strategic Overview

            15.2.3.4. SWOT Analysis

        15.2.4. Planmed Oy

            15.2.4.1. Company Description

            15.2.4.2. Business Overview

            15.2.4.3. Strategic Overview

            15.2.4.4. SWOT Analysis

        15.2.5. Hologic, Inc.

            15.2.5.1. Company Description

            15.2.5.2. Business Overview

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

Choose License Type

Checkout Inquiry Sample